Treatment of Pancreatic Divisum

Key Clinical Context

The American Gastroenterological Association notes that the vast majority of patients with pancreatic divisum (occurring in 6-10% of the population) remain asymptomatic throughout their lives 3
Treatment should only be pursued in the subset with documented symptomatic disease—specifically recurrent acute pancreatitis episodes, not chronic pain alone, as recommended by the American Gastroenterological Association 1, 4

The American Gastroenterological Association recommends that EUS is the preferred initial diagnostic test after standard workup is unrevealing, as it can identify other causes of recurrent pancreatitis and assess for complications 3, 4
MRI/MRCP serves as a complementary or alternative test to EUS and is particularly helpful for identifying pancreatic ductal anatomical variants like pancreatic divisum, according to the American Gastroenterological Association 3, 5
Imaging should be performed 2-6 weeks after acute episode resolution to avoid inflammatory changes that obscure evaluation, as suggested by the American Gastroenterological Association 3, 6

The American Gastroenterological Association suggests that best candidates for endoscopic therapy are patients with radiologic evidence of outflow obstruction (dilated dorsal pancreatic duct and/or santorinicele) 1, 2
Minor papilla sphincterotomy is the preferred contemporary approach, not stent placement alone, as recommended by the American Gastroenterological Association 3, 2
Stenting alone is inadequate as it doesn't produce durable reshaping of the dorsal drainage system and requires frequent exchanges with risk of migration, occlusion, and ductal injury, according to the American Gastroenterological Association 3, 5
Post-ERCP pancreatitis risk is 10-15%, and post-papillotomy stenosis occurs in up to 19% of patients, as noted by the American Gastroenterological Association 2
There is no role for ERCP to treat pain alone in patients with pancreatic divisum, as stated by the American Gastroenterological Association 1, 4
Asymptomatic patients should not undergo intervention, and patients without objective signs of obstruction have poor response rates, according to the American Gastroenterological Association 3, 5, 2

The evidence supporting endoscopic therapy remains limited and controversial, with only one small randomized trial showing benefit of minor papilla stenting, as noted by the American Gastroenterological Association 3, 6
Most data comes from retrospective uncontrolled studies with heterogeneous populations and interventions, according to the American Gastroenterological Association 3, 2
An ongoing international multicenter randomized sham-controlled trial evaluating minor papilla sphincterotomy should provide definitive clarity, as suggested by the American Gastroenterological Association 3, 2